Griseofulvin Tablets bulk supplier for pharma manufacturers

Griseofulvin Tablets 125 mg, 250 mg, 500 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 125 mg, 250 mg, 500 mg

Reference Brands: Grifulvin V(US); Griséofulvine(EU)

Griseofulvin inhibits fungal cell mitosis by disrupting microtubule formation, preventing fungal replication. It effectively treats dermatophyte skin, hair, and nail infections. Benefits include targeted oral therapy, good tissue penetration, and proven efficacy against dermatophytes, making it a reliable option for managing superficial fungal infections.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Griseofulvin tablets are approved in the EU and US for treating dermatophyte skin infections. In the EU, generic formulations are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval is based on comprehensive clinical data, with both branded and generic versions available. Both regions require detailed dossiers for approval and ongoing safety monitoring. For expert assistance with pharmaceutical dossiers, regulatory submissions, and compliance, visit PharmaTradz. We help facilitate smooth market access for griseofulvin tablets, ensuring adherence to European and American standards for effective treatment of dermatophyte infections.

Griseofulvin Tablets — third party manufacturing & bulk supply

Griseofulvin Tablets 125 mg, 250 mg, 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Griseofulvin Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Griseofulvin Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Griseofulvin Tablets →

Back to Listing

Frequently Asked Questions

Griseofulvin is used to treat fungal infections of the skin, hair, and nails caused by dermatophytes such as tinea capitis, tinea corporis, tinea pedis, and tinea unguium. It works by disrupting fungal cell division and binding to keratin, allowing new, healthy tissue to grow and replace the infected areas.

Griseofulvin contains the antifungal compound griseofulvin, produced from the Penicillium species. It is formulated with pharmaceutical excipients that support proper absorption and therapeutic effectiveness after oral administration.

Common trade names include Grifulvin V and Gris-PEG, used in the USA and other global regions.

Grifulvin V and similar branded versions have been manufactured by companies such as Breckenridge Pharmaceutical and other licensed producers depending on the market. Various GMP-certified manufacturers also supply generic griseofulvin internationally.

The generic name is griseofulvin.

Common brand names include Grifulvin V and Gris-PEG.

Griseofulvin is manufactured in multiple GMP-certified facilities globally, including established production sites in the USA and Europe, along with several approved manufacturers providing generic griseofulvin to international markets.